The Companion Animal Pharmaceuticals Market is expected to be around US$ 21 Billion by 2028 at a CAGR of 7.5% in the given forecast period.
The increasing adoption of pets, rise in expenditure on animal health, and increasing initiatives of nonprofit organizations & government towards the health of companion animals are few factors which are fueling the growth of the market. Furthermore, there is an increase in the prevalence of zoonotic diseases among companion animals. Zoonotic diseases are caused by harmful germs such as parasites, fungi, bacteria & viruses and these gems can result in various types of illness among animals and also among humans. Therefore, it is necessary to protect the animals from these diseases which require proper vaccines and drugs. Due to these, most pharmaceuticals are involved in manufacturing of animal health drugs, vaccines, and medical devices for companion animals. These factors are responsible for the growth of the companion animal pharmaceuticals market.
The global Companion Animal Pharmaceuticals market is segregated on the basis of Indication as Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases and Other Indications. Based on Animal Type the global Companion Animal Pharmaceuticals market is segmented in Dogs, Cats, Horses and Other Companion Animals. Based on Distribution Channels the global Companion Animal Pharmaceuticals market is segmented in Veterinary Hospitals, Veterinary Clinics and Retail Pharmacies.
The global Companion Animal Pharmaceuticals market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Companion Animal Pharmaceuticals market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Ashish Life Science Pvt. Ltd., Boehringer Ingelheim GmbH, Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals plc, Eco Animal Health Group plc, Elanco Animal Health Incorporated, Endovac Animal Health, Hipra, Indian Immunologicals Ltd., Inovet, Kyoritsu Seiyaku, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Holdings Limited, and others are among the major players in the global Companion Animal Pharmaceuticals market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Companion Animal Pharmaceuticals Market has been segmented as below:
Companion Animal Pharmaceuticals Market, By Indication
Companion Animal Pharmaceuticals Market, By Animal Type
Companion Animal Pharmaceuticals Market, By Distribution Channels
Companion Animal Pharmaceuticals Market, By Region
Companion Animal Pharmaceuticals Market, By Company
The report covers:
Report Scope:
The global Companion Animal Pharmaceuticals market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Companion Animal Pharmaceuticals market share. Major industry players with significant revenue share include Ashish Life Science Pvt. Ltd., Boehringer Ingelheim GmbH, Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals plc, Eco Animal Health Group plc, Elanco Animal Health Incorporated, Endovac Animal Health, Hipra, Indian Immunologicals Ltd., Inovet, Kyoritsu Seiyaku, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Holdings Limited, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Veterinary/Animal Vaccines Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter’s Five Force Analysis
5. Companion Animal Pharmaceuticals Market, By Indication
5.1. Introduction
5.2. Infectious Diseases
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Dermatologic Diseases
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.4. Pain
5.4.1. Market Overview
5.4.2. Market Size and Forecast
5.5. Orthopedic Diseases
5.5.1. Market Overview
5.5.2. Market Size and Forecast
5.6. Behavioral Diseases
5.6.1. Market Overview
5.6.2. Market Size and Forecast
5.7. Other Indications
5.7.1. Market Overview
5.7.2. Market Size and Forecast
6. Companion Animal Pharmaceuticals Market, By Animal Type
6.1. Introduction
6.2. Dogs
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Cats
6.3.1. Market Overview
6.3.2. Market Size and Forecast
6.4. Horses
6.4.1. Market Overview
6.4.2. Market Size and Forecast
6.5. Other Companion Animals
6.5.1. Market Overview
6.5.2. Market Size and Forecast
7. Companion Animal Pharmaceuticals Market, By Distribution Channels
7.1. Introduction
7.2. Veterinary Hospitals
7.2.1. Market Overview
7.2.2. Market Size and Forecast
7.3. Veterinary Clinics
7.3.1. Market Overview
7.3.2. Market Size and Forecast
7.4. Retail Pharmacies
7.4.1. Market Overview
7.4.2. Market Size and Forecast
8. Companion Animal Pharmaceuticals Market, By Geography
8.1. Introduction
8.2. North America
8.2.1. North America Companion Animal Pharmaceuticals, By Indication
8.2.2. North America Companion Animal Pharmaceuticals, By Animal Type
8.2.3. North America Companion Animal Pharmaceuticals, By Distribution Channels
8.3. Europe
8.3.1. Europe Companion Animal Pharmaceuticals, By Indication
8.3.2. Europe Companion Animal Pharmaceuticals, By Animal Type
8.3.3. Europe Companion Animal Pharmaceuticals, By Distribution Channels
8.4. Asia-Pacific
8.4.1. Asia-Pacific Companion Animal Pharmaceuticals, By Indication
8.4.2. Asia-Pacific Companion Animal Pharmaceuticals, By Animal Type
8.4.3. Asia-Pacific Companion Animal Pharmaceuticals, By Distribution Channels
8.5. Rest of the World
8.5.1. Rest of the World Companion Animal Pharmaceuticals, By Indication
8.5.2. Rest of the World Companion Animal Pharmaceuticals, By Animal Type
8.5.3. Rest of the World Companion Animal Pharmaceuticals, By Distribution Channels
9. Competitive Insights
9.1. Key Insights
9.2. Company Market Share Analysis
9.3. Strategic Outlook
9.3.1. Mergers & Acquisitions
9.3.2. New Product Developments
9.3.3. Portfolio/Production Capacity Expansions
9.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5. Others
10. Company Profiles
10.1. Ashish Life Science Pvt. Ltd.
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. Boehringer Ingelheim GmbH
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Ceva Santé Animale
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. Chanelle Pharma
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. Dechra Pharmaceuticals plc
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
10.6. Eco Animal Health Group plc
10.6.1. Company Overview
10.6.2. Product/Service Landscape
10.6.3. Financial Overview
10.6.4. Recent Developments
10.7. Elanco Animal Health Incorporated
10.7.1. Company Overview
10.7.2. Product/Service Landscape
10.7.3. Financial Overview
10.7.4. Recent Developments
10.8. Endovac Animal Health
10.8.1. Company Overview
10.8.2. Product/Service Landscape
10.8.3. Financial Overview
10.8.4. Recent Developments
10.9. Hipra
10.9.1. Company Overview
10.9.2. Product/Service Landscape
10.9.3. Financial Overview
10.9.4. Recent Developments
10.10. Indian Immunologicals Ltd.
10.10.1. Company Overview
10.10.2. Product/Service Landscape
10.10.3. Financial Overview
10.10.4. Recent Developments
10.11. Inovet
10.11.1. Company Overview
10.11.2. Product/Service Landscape
10.11.3. Financial Overview
10.11.4. Recent Developments
10.12. Kyoritsu Seiyaku
10.12.1. Company Overview
10.12.2. Product/Service Landscape
10.12.3. Financial Overview
10.12.4. Recent Developments
10.13. Lutim Pharma Pvt. Ltd.
10.13.1. Company Overview
10.13.2. Product/Service Landscape
10.13.3. Financial Overview
10.13.4. Recent Developments
10.14. Merck & Co. Inc.
10.14.1. Company Overview
10.14.2. Product/Service Landscape
10.14.3. Financial Overview
10.14.4. Recent Developments
10.15. Norbrook Holdings Limited
10.15.1. Company Overview
10.15.2. Product/Service Landscape
10.15.3. Financial Overview
10.15.4. Recent Developments
The Companion Animal Pharmaceuticals Market has been segmented as below:
Companion Animal Pharmaceuticals Market, By Indication
Companion Animal Pharmaceuticals Market, By Animal Type
Companion Animal Pharmaceuticals Market, By Distribution Channels
Companion Animal Pharmaceuticals Market, By Region
Companion Animal Pharmaceuticals Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
